Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173525 | SCV000224646 | benign | not specified | 2015-05-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000173525 | SCV000314313 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000363346 | SCV000371488 | benign | Wilms tumor 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000309796 | SCV000371490 | benign | Nephrotic syndrome, type 4 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000364660 | SCV000371491 | benign | Meacham syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV000173525 | SCV000518965 | benign | not specified | 2016-03-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics Inc | RCV000576511 | SCV000677585 | benign | Drash syndrome; Frasier syndrome; Nephrotic syndrome, type 4; Wilms tumor 1 | 2017-04-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588463 | SCV000699503 | benign | not provided | 2016-05-26 | criteria provided, single submitter | clinical testing | Variant summary: The WT1 c.330C>T (p.Pro110Pro) variant causes a synonymous change involving a non-conserved nucleotide with 5/5 splice prediction tools predicting no significant effect on splicing and ESE finder predicting effects on ESE binding sites. This variant was found in the large, broad control population, ExAC, with an allele frequency of 1620/4996 (285 homozygotes, 1/3, frequency: 0.3242594), which significantly exceeds the estimated maximal expected allele frequency for a pathogenic WT1 variant of 1/106382 (0.0000094), suggesting this variant is likely a benign polymorphism. In addition, a reputable clinical laboratory cites the variant as "benign." Therefore, the variant of interest is classified as Benign. |
Invitae | RCV001516886 | SCV001725250 | benign | Drash syndrome; Frasier syndrome; Wilms tumor 1; 11p partial monosomy syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002243843 | SCV002515080 | benign | Drash syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002243842 | SCV002515081 | benign | Frasier syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000364660 | SCV002515082 | benign | Meacham syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000309796 | SCV002515083 | benign | Nephrotic syndrome, type 4 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000363346 | SCV002515084 | benign | Wilms tumor 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000363346 | SCV004016261 | benign | Wilms tumor 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV003588587 | SCV004360961 | benign | Nephroblastoma | 2019-03-28 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000173525 | SCV001740872 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000173525 | SCV001931216 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000173525 | SCV001963642 | benign | not specified | no assertion criteria provided | clinical testing |